Drug
Odiparcil clinical trials
- studies test it
- 3
- open now
- 0
- in phase 3
- 0
- first study started
- 2005
How studies write it
Studies that test it under each name
Name
- Odiparcil
- 3
Studies by the year they started
3 studies that test it; most in 2005 (1)
| Year | Studies |
|---|---|
| 2005 | 1 |
| 2006 | 1 |
| 2017 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 3 · Other 0
GlaxoSmithKline (2) · Inventiva Pharma (1)
Often tested with
Tested in the same studies.
Related medicines
As reviewed, each with the page that says it.
- One of Fibrinolytic Agents source
Studies
Open first, then newest update. How each study uses odiparcil is read from its arms, and is right about nine times in ten.
Testing it · 3
- A Study in MPS VI to Assess Safety and Efficacy of OdiparcilCompletedPhase 2Inventiva PharmaNCT03370653Written as Odiparcil
- Odiparcil For The Prevention Of Venous ThromboembolismCompletedPhase 2GlaxoSmithKlineNCT00244725Written as Odiparcil
- Odiparcil QT Definitive StudyTerminatedPhase 1GlaxoSmithKlineNCT00437242Written as Odiparcil
Codes
What other systems call odiparcil · ClinicalTrials.gg INT004988
- MeSH (NLM) C514804odiparcilOne source NLM
- UNII (FDA) FIK1414ZI8ODIPARCILConfirmed FDA, NLM, Wikidata
- Wikidata Q27278001odiparcilConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C87248OdiparcilOne source FDA
- DrugBank DB06609One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C514804 | odiparcil | One source NLM |
| UNII (FDA) | FIK1414ZI8 | ODIPARCIL | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q27278001 | odiparcil | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C87248 | Odiparcil | One source FDA |
| DrugBank | DB06609 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.